Tesamorelin: Sourcing, Purity, and Verification Standards
How SpartaLabs sources, tests, and verifies tesamorelin for research applications. Educational reference.

Trans-3-hexenoyl GHRH(1-44) analogue. Lyophilized. ≥ 99% purity.
In Stock
Tesamorelin is a synthetic 44-amino-acid analogue of human growth-hormone releasing hormone (GHRH) with a trans-3-hexenoyl group attached to the N-terminal tyrosine to confer stability against dipeptidyl peptidase-4 cleavage.
It is a reference long-acting GHRH analogue in preclinical literature on GH-axis pulsatility and lipid-metabolism signalling models.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples refrigerated. For laboratory and research use only. Not for human or veterinary use.
Every batch of Tesamorelin is independently tested by a third-party laboratory. Certificates of Analysis include HPLC purity testing, mass spectrometry confirmation, and sterility verification.
Contact us at info@spartalabs.net to request the COA for this product.
Orders are processed within 1–2 business days. Standard shipping typically takes 3–5 business days within the continental United States.
All products are shipped in temperature-controlled, discreet packaging to ensure product integrity.
Tesamorelin is a synthetic 44-amino-acid analogue of human growth-hormone releasing hormone (GHRH) with a trans-3-hexenoyl group attached to the N-terminal tyrosine to confer stability against dipeptidyl peptidase-4 cleavage.
It is a reference long-acting GHRH analogue in preclinical literature on GH-axis pulsatility and lipid-metabolism signalling models.
Lyophilized under inert atmosphere. Reconstitute with sterile bacteriostatic water; store reconstituted samples refrigerated. For laboratory and research use only. Not for human or veterinary use.
How SpartaLabs sources, tests, and verifies tesamorelin for research applications. Educational reference.
A bibliographic summary of published clinical and pharmacological research on tesamorelin — pivotal trials, GH-axis pharmacodynamics, hepatic outcomes, and active research frontiers. Educational reference.
A research-library overview of tesamorelin — chemistry, GHRH-analog pharmacology, FDA approval history, and discovery lineage of this synthetic peptide. Educational reference.
A research-focused examination of tesamorelin's reported mechanism — GHRH receptor binding, GH-axis signaling cascade, and pharmacological basis for its activity as a GHRH analog. Educational reference.
A chronological account of tesamorelin's development — from the isolation of endogenous GHRH in 1982 through Theratechnologies' clinical program, FDA approval of Egrifta in 2010, and continued research through 2025. Educational reference.
Peptide0.9% Benzyl Alcohol Preserved Water. Sterile. 10ml vial.
PeptideBacteriostatic Water for Research. Sterile. 10ml vial.
PeptideTetra-substituted GHRH analogue with Drug Affinity Complex. Lyophilized.
PeptideCo-lyophilized 10 mg BPC-157 / 10 mg TB-500. ≥ 99% purity.
PeptideFour-peptide blend: GHK-Cu, TB-500, BPC-157, KPV. 80 mg total. Lyophilized.
PeptideCo-lyophilized 5 mg BPC-157 / 5 mg TB-500. ≥ 99% purity.
PeptideSynthetic hexapeptide ghrelin-receptor agonist. Lyophilized.
PeptideSynthetic tetrapeptide (Ala-Glu-Asp-Gly). Lyophilized.
PeptideSynthetic pentadecapeptide. Lyophilized. ≥ 99% purity.
PeptideLong-acting amylin analogue. Lyophilized. ≥ 99% purity.
PeptideTetra-substituted GHRH (1-29) analogue, no DAC. Lyophilized. ≥ 99% purity.
PeptideModified C-terminal fragment (Tyr-hGH 177-191) of human growth hormone. Lyophilized.
No reviews yet. Be the first verified buyer to share your experience from your account → orders page after your shipment arrives.
Reviews are open to verified buyers from your account → orders page. Every submission is moderated for compliance — we filter human-use and medical claims evenhandedly across positive and negative reviews. See our review moderation policy for the exact rules and 1–2 business-day review window.